Jay Lusk, MD, MBA

@jayblusk.bsky.social

Preventive medicine/public health physician, clinical data scientist. Driven to prevent chronic disease with big data. MD/MBA at Duke, currently preventive medicine residency at UNC. jaylusk.md

Maybe instead grants, early career investigators will need to support their work through affiliate links and corporate brand deals in our manuscripts. “Acknowledgements: We thank Peloton for supporting our work. Use the code ‘Green’ for 10% off a yearly subscription of workouts!”🧪🛟 #MedSky

Dr Kathleen Millen@neurodevkathy.bsky.social · 2y ago

#NIH #NINDS paylines are at 8% for fiscal 2025. Tough year is due to increased research costs and federal budget uncertainty for FY 2025. Director's message here. Worth reading. www.ninds.nih.gov/news-events/...

New paper on how to calculate a multistate death distribution! What's that, you ask? Usually, we plot a death distribution by age at death. But age at death is the sum of our time spent in different states. If we split time between being healthy or not, then the distribution is multistate (1/3)

a multistate death distribution. This plot has healthy years in x, unhealthy years in y, and x+y (descending diagonals) is age at death. We display the death distribution as filled contours. The health measure in question is ADLs, which has a high mortality penalty, so the distribution mostly hugs the lower axis. state expectancies and total life expectancy converge on a point. SHARE data, females, ADL, 2015-17.

State medical board records have some amazing stories. Take this one. PA applies for a license in NC, submits license documentation. States she had changed her name, provides documents. Sounds legit. Licensed approved. Turns out, SHE STOLE ANOTHER PA’s identity?! License summarily suspended.

BildBild

Intensive BP control stands out. We shouldn’t be exposing healthy 80 year old patients to chronic poorly controlled BP. Care required to avoid orthostatic hypotension and falls, but the consequences of undertreated HTN are dire. So much therapeutic nihilism about this… #MedSky #CardioSky #GeriSkys

Eric Widera, MD@ewidera.bsky.social · 2y ago

Medicine focuses a lot on the question “will this help my patient” but not on the question “when will it help my patient.” The latter becomes important as we age. We’ve developed a “time-to-benefit” tool on eprognosis.ucsf.edu to help answer this question. Here is a snapshot #MedSky #FOAMed #meded

Small, retrospective study evaluating CPAP for secondary prevention of CVD after AMI. As expected, long-term adherence to CPAP (>4 hours per night) is associated with 50% decreased risk of recurrent MACCE. I suspect impact on #htn control may drive effect. Need for larger and prospective studies.

Bild

Incredible evidence to support more focus on control of #htn. Hyperglycemia is not the only contributor to CVD risk in T2DM. We can’t be content with SBPs in the 130s. Time to tackle therapeutic inertia in HTN treatment!

Wanpen Vongpatanasin@drwanpen.bsky.social · 2y ago

Amazing results from BPROAD trial showing lowering BP in T2DM to SBP<120 vs <140 mmHg reduces 4 points MACE HR0.79(.69-.9). Will be interesting to see how many are on SGLT2i or GLP1ra #AHA24